Method for affecting urinary function with electrode implantation in adipose tissue

• US 7,343,202 B2
• Filed: 06/10/2005
• Issued: 03/11/2008
• Est. Priority Date: 02/12/2004
• Status: Active Grant

• Current Assignee: Medtronic Urinary Solutions, Inc. (Medtronic Plc)
• Original Assignee: NDI Medical, LLC
• Inventors: Grill, Julie, Strother, Robert B., Mrva, Joseph J., Thrope, Geoffrey B., Bennett, Maria
• Primary Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US11/150,419
• Publication Number:
  US 20060004429A1
• Time in Patent Office: 1,005 Days
• Field of Search: 607/39, 607 40- 41, 607/116, 607/126, 607/128, 607/138, 607/143
• US Class Current: 607/41
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/0524 Vaginal electrodes
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/0558 Anchoring or fixation means therefor
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/372 Arrangements in connection with the implantation of stimulators

Abstract

Systems and methods provide a stimulation electrode assembly comprising an elongated lead sized and configured to be implanted within an adipose tissue region. The lead includes an electrically conductive portion to apply electrical stimulation to nerve or muscle in the adipose tissue region and at least one expandable anchoring structure deployable from the lead to engage adipose tissue and resist dislodgment and/or migration of the electrically conductive portion within the adipose tissue region.

Claims

1. A method comprising,

providing a stimulation electrode assembly, comprising an elongated lead sized and configured to be implanted in adipose tissue, the lead including an electrically conductive portion to apply electrical stimulation to nerve tissue innervating the adipose tissue, and at least one expandable anchoring structure deployable from the lead to engage adipose tissue and resist dislodgment and/or migration of the electrically conductive portion within adipose tissue,

selecting within the adipose tissue an adipose tissue region at or near a pubic symphysis innervated by a nerve affecting urinary function,

implanting the electrically conductive portion and at least one expandable anchoring structure in the selected adipose tissue region, with the expandable anchoring structure deploying and engaging adipose tissue to resist dislodgment and/or migration of the electrically conductive portion within the selected adipose tissue region, and

conveying electrical stimulation waveforms through the stimulation electrode assembly to achieve selective stimulation of the nerve to affect urinary function.

2. A method according to claim 1,

wherein the selected adipose tissue region is innervated by a left and/or tight branch of the dorsal genital nerve.

3. A method according to claim 1, wherein implanting the electrically conductive portion and at least one expandable anchoring structure in the selected adipose tissue region includes

placing the expandable anchoring structure in a collapsed condition,

implanting the electrically conductive portion and the expandable anchoring structure in the selected adipose tissue region, and

expanding the anchoring structure into the adipose tissue to resist dislodgment and/or migration of the electrically conductive portion within the selected adipose tissue region.

4. A method according to claim 3,

wherein the expandable anchoring structure, when in the expanded condition, assumes an open, proximal-pointing configuration that resists proximal passage of the lead through adipose tissue in response to a pulling force that is less than or equal to a threshold axial force level.

5. A method according to claim 4,

wherein the open, proximal-pointing configuration yields to permit proximal passage of the lead through adipose tissue in response to a pulling force that is greater than the threshold axial force level.

6. A method according to claim 3,

further including providing a sleeve having an interior bore sized and configured to create percutaneous access to adipose tissue, and

wherein implanting the electrically conductive portion and at least one expandable anchoring structure in the selected adipose tissue region includes passing the electrically conductive portion and at least one expandable anchoring structure through the interior bore of the sleeve, the interior bore of the sleeve retaining the expandable anchoring structure in the collapsed condition to accommodate passage of the electrically conductive portion and the expandable anchoring structure through the interior bore into the selected adipose tissue region.

7. A method according to claim 3,

wherein the expandable anchoring structure is normally biased toward the expanded condition.

8. A method according to claim 7,

further including providing a sleeve having an interior bore sized and configured to create percutaneous access to adipose tissue,

wherein implanting the electrically conductive portion and at least one expandable anchoring structure in the selected adipose tissue region includes passing the electrically conductive portion and at least one expandable anchoring structure through the interior bore of the sleeve, the interior bore of the sleeve retaining the expandable anchoring structure in the collapsed condition to accommodate passing of the electrically conductive portion and the expandable anchoring structure through the interior bore into the selected adipose tissue region, and

wherein upon passing the electrically conductive portion and the expandable anchoring structure into the adipose tissue region, the expandable anchoring structure returns toward the normally biased expanded condition.

9. A method according to claim 1,

wherein the expandable anchoring structure comprises an array of circumferentially spaced-apart, radiating tines, and

wherein implanting the electrically conductive portion and the expandable anchoring structure in the selected adipose tissue region includes

placing the array of circumferentially spaced-apart, radiating tines in a collapsed condition,

implanting the electrically conductive portion and the array of circumferentially spaced-apart, radiating tines in the selected adipose tissue region, and

expanding the array of circumferentially spaced-apart, radiating tines into the adipose tissue to resist dislodgment and/or migration of the electrically conductive portion within the selected adipose tissue region.

10. A method according to claim 9,

wherein the array of circumferentially spaced-apart, radiating tines forms an open structure that enlarges in diameter from distal to proximal to resist proximal passage of the lead through the adipose tissue region.

11. A method according to claim 1,

wherein the stimulation electrode assembly comprising at least two expandable anchoring structures, and

wherein implanting the electrically conductive portion and at least two expandable anchoring structures in the selected adipose tissue region includes

placing the expandable anchoring structures in a collapsed condition,

implanting the electrically conductive portion and the expandable anchoring structures in the selected adipose tissue region, and

expanding the anchoring structures into the adipose tissue to resist dislodgment and/or migration of the electrically conductive portion within the selected adipose tissue region.

12. A method according to claim 1,

wherein the lead includes a distal section, and wherein the electrically conductive portion is at or near the distal section, and wherein the expandable anchoring structure is proximal to the electrically conductive portion.

13. A method according to claim 1,

wherein the expandable anchoring structure comprises a polymer material.

14. A method according to claim 1,

wherein the urinary function is urinary urge incontinence.

15. A method according to claim 1,

wherein the urinary function is stress incontinence.

16. A method according to claim 1,

wherein the urinary function is mixed urinary urge incontinence and stress incontinence.

17. A method according to claim 1,

further including providing an implantable pulse generator sized and configured to be positioned subcutaneous to a tissue surface in an anterior pelvic region remote from the at least one electrically conductive portion,

implanting the implantable pulse generator in an anterior pelvic region remote from the at least one electrically conductive surface,

coupling the implantable pulse generator to the stimulation electrode assembly, and

wherein conveying electrical stimulation waveforms includes operating the implantable pulse generator to convey electrical stimulation waveforms through the stimulation electrode assembly to achieve selective stimulation of the nerve to affect urinary function.

18. A method according to claim 17,

further including programming and/or interrogating the implantable pulse generator using transcutaneous communication circuitry.

19. A method according to claim 1,

further including providing an external pulse generator sized and configured to convey electrical stimulation waveforms through the stimulation electrode assembly,

coupling the external pulse generator to the stimulation electrode assembly, and

wherein conveying electrical stimulation waveforms includes operating the external pulse generator to convey electrical stimulation waveforms through the stimulation electrode assembly to achieve selective stimulation of the nerve to affect urinary function.

20. A method according to claim 19,

further including providing an implantable pulse generator sized and configured to be positioned subcutaneous to a tissue surface in an anterior pelvic region remote from the at least one electrically conductive portion,

uncoupling the stimulation electrode assembly from the external pulse generator and coupling the implantable pulse generator to the stimulation electrode assembly,

implanting the pulse generator m an anterior pelvic region remote from the at least one electrically conductive portion, and

wherein conveying electrical stimulation waveforms includes operating the implantable pulse generator to convey electrical stimulation waveforms through the stimulation electrode assembly to achieve selective stimulation of the nerve to affect urinary function.